NYSEARCA:ARKG - ARK Genomic Revolution Multi-Sector ETF Stock Price, News & Analysis

$32.38
+1.21 (+3.88 %)
(As of 08/18/2019 04:00 PM ET)
Add
Today's Range
$31.43
Now: $32.38
$32.41
50-Day Range
$31.50
MA: $33.69
$35.28
52-Week Range
$21.98
Now: $32.38
$35.54
Volume88,400 shs
Average Volume145,135 shs
Market Capitalization$440.53 million
P/E RatioN/A
Dividend Yield0.87%
BetaN/A

Basic Details

Issuer ARK
Fund NameARK Genomic Revolution Multi-Sector ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:ARKG
Inception Date10/30/2014
Fund ManagerCatherine D. Wood
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNot Applicable
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$440.20 million
Average Daily Volume$132,293.70
Discount/Premium0.02%

ETF Expenses

Management Fee0.75%
Other Expenses0.00%
Total Expenses0.75%
Fee Waiver0.00%
Net Expenses0.75%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorARK Investment Management LLC
CustodianThe Bank of New York Mellon Corporation
DistributorForeside Fund Services, LLC
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerJane Street

Receive ARKG News and Ratings via Email

Sign-up to receive the latest news and ratings for ARKG and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG)
Currency Exposure of ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG)
Sector Exposure of ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG)
Industry Exposure of ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG)

ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG) Frequently Asked Questions

What is ARK Genomic Revolution Multi-Sector ETF's stock symbol?

ARK Genomic Revolution Multi-Sector ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "ARKG."

How often does ARK Genomic Revolution Multi-Sector ETF pay dividends? What is the dividend yield for ARK Genomic Revolution Multi-Sector ETF?

ARK Genomic Revolution Multi-Sector ETF declared a special dividend on Thursday, December 27th. Stockholders of record on Friday, December 28th will be given a dividend of $0.1964 per share on Monday, December 31st. The ex-dividend date is Thursday, December 27th. This is an increase from ARK Genomic Revolution Multi-Sector ETF's previous special dividend of $0.13. View ARK Genomic Revolution Multi-Sector ETF's Dividend History.

Has ARK Genomic Revolution Multi-Sector ETF been receiving favorable news coverage?

Headlines about ARKG stock have trended negative recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. ARK Genomic Revolution Multi-Sector ETF earned a news sentiment score of -2.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for ARK Genomic Revolution Multi-Sector ETF.

What other stocks do shareholders of ARK Genomic Revolution Multi-Sector ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARK Genomic Revolution Multi-Sector ETF investors own include NVIDIA (NVDA), ARK Innovation ETF (ARKK), Baidu (BIDU), Johnson & Johnson (JNJ), Weyerhaeuser (WY), Alibaba Group (BABA), Twilio (TWLO), Ctrip.Com International (CTRP), Paypal (PYPL) and Invesco QQQ Trust (QQQ).

Who are ARK Genomic Revolution Multi-Sector ETF's major shareholders?

ARK Genomic Revolution Multi-Sector ETF's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Carroll Financial Associates Inc. (2.71%), Cambridge Investment Research Advisors Inc. (0.87%), Janney Montgomery Scott LLC (0.06%), Certified Advisory Corp (0.04%), Migdal Insurance & Financial Holdings Ltd. (0.02%) and Steward Partners Investment Advisory LLC (0.01%).

Which major investors are buying ARK Genomic Revolution Multi-Sector ETF stock?

ARKG stock was acquired by a variety of institutional investors in the last quarter, including Cambridge Investment Research Advisors Inc., Carroll Financial Associates Inc., Janney Montgomery Scott LLC, Steward Partners Investment Advisory LLC, Certified Advisory Corp, Migdal Insurance & Financial Holdings Ltd. and Financial Gravity Wealth Inc..

How do I buy shares of ARK Genomic Revolution Multi-Sector ETF?

Shares of ARKG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ARK Genomic Revolution Multi-Sector ETF's stock price today?

One share of ARKG stock can currently be purchased for approximately $32.38.

How big of a company is ARK Genomic Revolution Multi-Sector ETF?

ARK Genomic Revolution Multi-Sector ETF has a market capitalization of $440.53 million. View Additional Information About ARK Genomic Revolution Multi-Sector ETF.


MarketBeat Community Rating for ARK Genomic Revolution Multi-Sector ETF (NYSEARCA ARKG)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  35 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  65
MarketBeat's community ratings are surveys of what our community members think about ARK Genomic Revolution Multi-Sector ETF and other stocks. Vote "Outperform" if you believe ARKG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARKG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel